Advanced search
Publication Cover
Current Medical Research and Opinion Volume 28, 2012 - Issue 2
Submit an article Journal homepage
699
Views
14
CrossRef citations to date
0
Altmetric
Respiratory: Original Article

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease

Nanshan ZhongState Key Lab of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical College Guangzhou, China
,
Jinping ZhengState Key Lab of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical College Guangzhou, ChinaCorrespondence[email protected]
,
Fuqiang WenWest China Hospital, Sichuan University Chengdu, China
,
Lan YangFirst Affiliated Hospital of Medical College of Xi’an Jiaotong University Xi’an, China
,
Ping ChenGeneral Hospital of Shenyang Military Command Shenyang, China
,
Qingyu XiuShanghai Changzheng Hospital Shanghai, China
,
Wanzhen YaoPeking University Third Hospital Beijing, China
,
Tieying SunBeijing Hospital Beijing, China
,
Ziwen ZhaoGuang Zhou First Municipal People’s Hospital Guangzhou, China
,
Huahao ShenSecond Affiliated Hospital Zhejiang University College of Medicine Hangzhou, China
,
Yi ShiNanjing General Hospital of Nanjing Military Command Nanjing, China
,
Jiangtao LinChina–Japan Friendship Hospital Beijing, China
&
Qiang LiShanghai Changhai Hospital Shanghai, China
 show all
Pages 257-265 | Accepted 25 Oct 2011, Published online: 20 Jan 2012

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Bin Tang, Jun Wang, Lin-lin Luo, Qiu-gen Li & Dan Huang. (2019) Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 757-766.
Read now
Yuji Oba & Nazir A Lone. (2014) Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 469-479.
Read now

Articles from other publishers (12)

Chen Wang, Ting Yang, Jian Kang, Rongchang Chen, Li Zhao, Huijie He, Pryseley N. Assam, Rong Su, Eric Bourne, Shaila Ballal, Kiernan DeAngelis & Paul Dorinsky. (2020) Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS. Advances in Therapy 37:4, pages 1591-1607.
Crossref
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Kivanc Yuksel. (2019) Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial. Clinical Drug Investigation 39:10, pages 991-1001.
Crossref
Gary T. Ferguson, Alberto Papi, Antonio Anzueto, Edward M. Kerwin, Christy Cappelletti, Elizabeth A. Duncan, Jack Nyberg & Paul Dorinsky. (2018) Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study. European Respiratory Journal 52:3, pages 1801334.
Crossref
Kyoung Hee Cho, Young Sam Kim, John A. Linton, Chung Mo Nam, Young Choi & Eun-Cheol Park. (2017) Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002–2013. Respiratory Medicine 130, pages 75-84.
Crossref
Yi-Hua Lin, Xi-Ning Liao, Li-Li Fan, Yue-Jin Qu, De-Yun Cheng & Yong-Hong Shi. (2017) Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D. PLOS ONE 12:8, pages e0183300.
Crossref
David A Scott, Bethan Woods, Juliette C Thompson, James F Clark, Neil Hawkins, Mike Chambers, Bartolome R. Celli & Peter Calverley. (2015) Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Pulmonary Medicine 15:1.
Crossref
Kayleigh M Kew, Sofia Dias & Christopher J Cates. (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Jin-Ping Zheng, Fu-Qiang Wen, Chun-Xue Bai, Huan-Ying Wan, Jian Kang, Ping Chen, Wan-Zhen Yao, Li-Jun Ma, Xia Li, Luca Raiteri, Marco Sardina, Yi Gao, Bai-Song Wang & Nan-Shan Zhong. (2014) Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. The Lancet Respiratory Medicine 2:3, pages 187-194.
Crossref
Jinping Zheng, Jinghua Yang, Xiangdong Zhou, Li Zhao, Fuxin Hui, Haoyan Wang, Chunxue Bai, Ping Chen, Huiping Li, Jian Kang, Manja Brose, Frank Richard, Udo-Michael Goehring & Nanshan Zhong. (2014) Roflumilast for the Treatment of COPD in an Asian Population. Chest 145:1, pages 44-52.
Crossref
Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes & Rebecca Normansell. (2013) Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease . Cochrane Database of Systematic Reviews 2018:3.
Crossref
U. S. Björnsdóttir, S. Gizurarson & U. Sabale. (2013) Potential negative consequences of non‐consented switch of inhaled medications and devices in asthma patients. International Journal of Clinical Practice 67:9, pages 904-910.
Crossref
Luis Javier Nannini, Phillippa Poole, Stephen J Milan & Annabel Kesterton. (2013) Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease . Cochrane Database of Systematic Reviews 2014:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.